查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678717

生物標記發現外包服務市場規模、佔有率、趨勢分析報告：按生物標記類型、治療領域、階段、最終用途、地區和細分市場進行預測，2025 年至 2030 年

Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Biomarker Type (Predictive, Safety), By Therapeutic Area (Oncology, Neurology), By Phase, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

生物標記發現外包服務市場的成長和趨勢

根據 Grand View Research, Inc. 的一份新報告，全球生物標記發現外包服務市場預計到 2030 年將達到 412.7 億美元，2025 年至 2030 年期間的複合年成長率為 19.4%。

由於生物標記在臨床試驗中的應用越來越多，以及製藥公司外包速度加快，生物標記研究的外包不斷成長，是該市場的主要成長要素。

此外，液態切片的普及也有望推動市場成長。液態切片可以分析血液、尿液和腦脊髓液等體液中的生物標記物，與傳統組織切片檢查相比，它具有多種優勢，包括侵入性較小、可以即時提供資訊。因此，液態切片的應用正在迅速成長，這一趨勢直接影響了對生物標記發現外包服務的需求。

預計體學技術的進步將在未來幾年推動市場成長。基因組學、蛋白質組學、代謝體學和其他體學技術的進步使得人們能夠識別新的生物標記。整合多個體學部分的資料通常有利於生物標記的識別。專門從事多體學資料整合的外包服務為此領域提供了寶貴的專業知識。

藥物開發和臨床測試的增加是推動市場成長的主要因素。生物標記在藥物開發中發揮關鍵作用，可幫助製藥公司確定合適的藥物目標、簡化臨床測試流程並選擇進行測試的患者群體。截至 2023 年，全球臨床試驗狀況顯示，ClinicalTrials.gov 上註冊了 452,604 項臨床試驗，其中 64,838 名積極招募參與者。與 2021 年初記錄的約 365,000 次註冊測試相比，這是一個顯著的成長，支撐了臨床研究領域的強勁和持續成長。

生物標記發現外包服務市場報告重點

  • 根據生物標記類型，替代終點部分在 2024 年佔據最大收入佔有率，為 54.88%。
  • 依治療領域，分為腫瘤學、神經病學、循環系統、自體免疫疾病等。
  • 按階段分類，生物標記識別部分將在 2024 年佔據市場最大的收益佔有率。
  • 根據最終用途，市場分為製藥公司、生技公司和其他公司。
  • 2024 年，北美生物標記發現外包服務業佔據最大的市場佔有率，為 43.96%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章生物標記發現外包服務市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 科技
    • 將人工智慧和巨量資料融入生物標記研究
    • 體學技術
    • 生物資訊學和雲端運算的作用
  • 定價模式分析
  • 價值鏈分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第 4 章生物標記發現外包服務市場：按生物標記類型進行的估計和趨勢分析

  • 生物標記發現外包服務市場，按生物標記類型：細分儀表板
  • 生物標記發現外包服務市場，依生物標記類型分類：變異分析
  • 依生物標記類型，2018-2030 年
  • 預測性生物標記
  • 預後生物標記
  • 安全生物標記
  • 委託端點

第 5 章生物標記發現外包服務市場：按治療領域進行的估計和趨勢分析

  • 生物標記發現外包服務市場（按治療領域）：細分儀表板
  • 生物標記發現外包服務市場（按治療領域）：差異分析
  • 依治療領域，2018-2030 年
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 自體免疫疾病
  • 其他

第6章生物標記發現外包服務市場：各階段的估計與趨勢分析

  • 生物標記發現外包服務市場（按階段）：細分儀表板
  • 生物標記發現外包服務市場（按階段）：波動分析
  • 按階段分類，2018 - 2030 年
  • 生物標記識別
  • 生物標記檢驗
  • 生物標記分析
  • 生物標記組開發
  • 生物標記選擇

第7章生物標記發現外包服務市場：按最終用途的估計和趨勢分析

  • 生物標記發現外包服務市場，按最終用途：細分儀表板
  • 生物標記發現外包服務市場，依最終用途分類：變異分析
  • 按最終用途分類，2018-2030 年
  • 製藥公司
  • 生技公司
  • 其他

第 8 章生物標記發現外包服務市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業分類
    • 市場領導者
    • 新參與企業
  • 公司市場佔有率/估值分析，2024 年
  • 公司簡介
    • Laboratory Corporation of America Holdings
    • Charles River Laboratories
    • Eurofins Scientific
    • Celerion
    • ICON plc.
    • Parexel International（MA）Corporation
    • Proteome Sciences
    • GHO Capital
    • Thermo Fisher Scientific Inc.
    • Evotec
Product Code: GVR-4-68040-139-0

Biomarker Discovery Outsourcing Services Market Growth & Trends:

The global biomarker discovery outsourcing services market size is expected to reach USD 41.27 billion by 2030, growing at a CAGR of 19.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The expansion of outsourced biomarker research, attributed to the increased utilization of biomarkers in clinical trials and the accelerating level of outsourcing undertaken by pharmaceutical firms are key growth factors for this market.

Furthermore, increasing adoption of liquid biopsies is expected to drive the market growth. Liquid biopsies, which involve the analysis of biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid, offer several advantages over traditional tissue biopsies, such as being less invasive and providing real-time information. As a result, the adoption of liquid biopsies has been growing rapidly, and this trend directly impacts the demand for biomarker discovery outsourcing services.

Advancements in omics technologies are expected to drive market growth in the coming years. Progress in genomics, proteomics, metabolomics, and other omics technologies has enabled the identification of novel biomarkers.Integrating data from many omics disciplines can often be advantageous for biomarker identification. This all-encompassing approach enables a more thorough comprehension of complex disorders and can result in identifying reliable, multidimensional biomarkers.Outsourcing services specializing in multi-omics data integration offer valuable expertise in this area.

An increase in drug development and clinical trials is a major contributing factor to the market growth. Biomarkers play a crucial role in drug development, helping pharmaceutical companies identify suitable drug targets, streamline clinical trial processes, and select patient populations for trials.As of 2023, the global clinical trial landscape boasts 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This reflects a notable surge compared to the roughly 365,000 registered trials documented in early 2021, underscoring the robust and ongoing growth within the field of clinical research.

Biomarker Discovery Outsourcing Services Market Report Highlights:

  • Based on biomarker type, the surrogate endpoints segment accounted for the largest revenue share of 54.88% in 2024.
  • Based on therapeutic areas, the market includes oncology, neurology, cardiology, autoimmune diseases, and others.
  • Based on the discovery phase, in 2024, the biomarker identification segment accounted for the largest revenue share in the market.
  • Based on end use, the market is segmented into pharmaceutical companies, biotechnology companies, and others.
  • The biomarker discovery outsourcing services industry in North America accounted for the largest market share of 43.96% in 2024.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Demand for Biomarkers in Drug Development
      • 3.2.1.2. Expanding R&D Investment in Biopharmaceuticals
      • 3.2.1.3. Rising Prevalence of Chronic and Infectious Diseases
      • 3.2.1.4. Increasing focus on personalized medicine and targeted therapies
      • 3.2.1.5. Advancements in Omics Technologies
      • 3.2.1.6. Increasing Role of CROs and CDMOs Owing to Cost and Time Efficiency
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited Reproducibility & Validation Challenges
      • 3.2.2.2. High Cost of Biomarker Discovery & Validation
      • 3.2.2.3. Data Privacy & Security Concerns
  • 3.3. Technology Landscape
    • 3.3.1. Integration of AI and Big Data in Biomarker Research
    • 3.3.2. Omics Technologies
    • 3.3.3. Role of Bioinformatics & Cloud Computing
  • 3.4. Pricing Model Analysis
  • 3.5. Value Chain Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Biomarker Discovery Outsourcing Services Market: Biomarker Type Estimates & Trend Analysis

  • 4.1. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Segment Dashboard
  • 4.2. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Movement Analysis
  • 4.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Biomarker Type, 2018 - 2030 (USD Million)
  • 4.4. Predictive Biomarkers
    • 4.4.1. Predictive Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Prognostic Biomarkers
    • 4.5.1. Prognostic Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Safety Biomarkers
    • 4.6.1. Safety Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Surrogate Endpoints
    • 4.7.1. Surrogate Endpoints Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Segment Dashboard
  • 5.2. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Movement Analysis
  • 5.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cardiology
    • 5.6.1. Cardiology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Autoimmune Diseases
    • 5.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Other Therapeutic Area
    • 5.8.1. Other Therapeutic Area Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biomarker Discovery Outsourcing Services Market: Discovery Phase Estimates & Trend Analysis

  • 6.1. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Segment Dashboard
  • 6.2. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Movement Analysis
  • 6.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Discovery Phase, 2018 - 2030 (USD Million)
  • 6.4. Biomarker Identification
    • 6.4.1. Biomarker Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Biomarker Validation
    • 6.5.1. Biomarker Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Biomarker Profiling
    • 6.6.1. Biomarker Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Biomarker Panel Development
    • 6.7.1. Biomarker Panel Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Biomarker Selection
    • 6.8.1. Biomarker Selection Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biomarker Discovery Outsourcing Services Market: End Use Estimates & Trend Analysis

  • 7.1. Biomarker Discovery Outsourcing Services Market, By End Use: Segment Dashboard
  • 7.2. Biomarker Discovery Outsourcing Services Market, By End Use: Movement Analysis
  • 7.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Biotechnology Companies
    • 7.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Biomarker Discovery Outsourcing Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Laboratory Corporation of America Holdings
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Charles River Laboratories
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Eurofins Scientific
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Celerion
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. ICON plc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Parexel International (MA) Corporation
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Proteome Sciences
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. GHO Capital
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Thermo Fisher Scientific Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Evotec
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table. 1 List of Secondary Sources
  • Table. 2 List of Abbreviations
  • Table. 3 Global Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 4 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 5 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 6 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 7 Global Biomarker Discovery Outsourcing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table. 8 North America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table. 9 North America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 10 North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 11 North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 12 North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 13 U.S. Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 14 U.S. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 15 U.S. Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 16 U.S. Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 17 Canada Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 18 Canada Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 19 Canada Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 20 Canada Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 21 Mexico Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 22 Mexico Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 23 Mexico Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 24 Mexico Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 25 Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table. 26 Europe Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 27 Europe Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 28 Europe Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 29 Europe Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 30 Germany Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 31 Germany Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 32 Germany Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 33 Germany Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 34 UK Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 35 UK Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 36 UK Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 37 UK Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 38 France Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 39 France Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 40 France Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 41 France Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 42 Italy Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 43 Italy Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 44 Italy Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 45 Italy Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 46 Spain Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 47 Spain Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 48 Spain Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 49 Spain Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 50 Denmark Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 51 Denmark Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 52 Denmark Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 53 Denmark Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 54 Sweden Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 55 Sweden Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 56 Sweden Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 57 Sweden Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 58 Norway Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 59 Norway Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 60 Norway Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 61 Norway Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 62 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table. 63 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 64 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 65 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 66 Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 67 China Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 68 China Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 69 China Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 70 China Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 71 Japan Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 72 Japan Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 73 Japan Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 74 Japan Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 75 India Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 76 India Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 77 India Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 78 India Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 79 South Korea Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 80 South Korea Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 81 South Korea Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 82 South Korea Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 83 Australia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 84 Australia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 85 Australia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 86 Australia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 87 Thailand Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 88 Thailand Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 89 Thailand Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 90 Thailand Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 91 Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table. 92 Latin America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 93 Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 94 Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 95 Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 96 Brazil Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 97 Brazil Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 98 Brazil Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 99 Brazil Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 100 Argentina Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 101 Argentina Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 102 Argentina Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 103 Argentina Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 104 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
  • Table. 105 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 106 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 107 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 108 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 109 South Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 110 South Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 111 South Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 112 South Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 113 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 114 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 115 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 116 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 117 UAE Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 118 UAE Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 119 UAE Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 120 UAE Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table. 121 Kuwait Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
  • Table. 122 Kuwait Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table. 123 Kuwait Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
  • Table. 124 Kuwait Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Biomarker Discovery Outsourcing Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Biomarker Discovery Outsourcing Services, for Predictive Biomarkers, 2018 - 2030 (USD Million)
  • Fig. 13 Global Biomarker Discovery Outsourcing Services, for Prognostic Biomarkers, 2018 - 2030 (USD Million)
  • Fig. 14 Global Biomarker Discovery Outsourcing Services, for Safety Biomarkers, 2018 - 2030 (USD Million)
  • Fig. 15 Global Biomarker Discovery Outsourcing Services, for Surrogate Endpoints, 2018 - 2030 (USD Million)
  • Fig. 16 Global Biomarker Discovery Outsourcing Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biomarker Discovery Outsourcing Services, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Biomarker Discovery Outsourcing Services, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 19 Global Biomarker Discovery Outsourcing Services, for Autoimmune Diseases, 2018 - 2030 (USD Million)
  • Fig. 20 Global Biomarker Discovery Outsourcing Services, for Other Therapeutic Area, 2018 - 2030 (USD Million)
  • Fig. 21 Global Biomarker Discovery Outsourcing Services, for Biomarker Identification, 2018 - 2030 (USD Million)
  • Fig. 22 Global Biomarker Discovery Outsourcing Services, for Biomarker Validation, 2018 - 2030 (USD Million)
  • Fig. 23 Global Biomarker Discovery Outsourcing Services, for Biomarker Profiling, 2018 - 2030 (USD Million)
  • Fig. 24 Global Biomarker Discovery Outsourcing Services, for Biomarker Panel Development, 2018 - 2030 (USD Million)
  • Fig. 25 Global Biomarker Discovery Outsourcing Services, for Biomarker Selection, 2018 - 2030 (USD Million)
  • Fig. 26 Global Biomarker Discovery Outsourcing Services, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 27 Global Biomarker Discovery Outsourcing Services, for Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Biomarker Discovery Outsourcing Services, for Other End Use, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Outlook, 2024 & 2030
  • Fig. 30 North America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 MEA Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)